Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006)

Europace

Volumn 10, Issue 4, 2008, Pages 453-457

  Scott, P A ^a   Gorman, S ^b   Andrews, N P ^b   Roberts, P R ^a   Kalra, P R ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Guidelines; Implantable cardioverter defibrillators; National Institute for Health and Clinical Excellence; Sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; HEART DEATH; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; CLINICAL AUDIT; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; GREAT BRITAIN; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 44449102110     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun042     Document Type: Article

References (18)

1. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. TA95 Implantable cardioverter defibrillators for arrhythmias. http://guidance.nice.org.uk/TA95/guidance/pdf/English.
4. Plummer CJ, McComb JM. An audit of the implications of implementing NICE guidance on the use of implantable cardioverter defibrillators. Heart 2003;89:787-8.
5. Plummer CJ, Irving J, McComb JM. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005;7:266-72.
6. Plummer CJ, Irving RJ, Mccomb JM. Implications of national guidance for implantable cardioverter defibrillation implantation in the United Kingdom. Pacing Clin Electrophysiol 2003;26:479-82.
7. Buxton AE, Lee KE, DiCarlo L, Gold MR, Greer GS, Prystowsky EN et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-45.
8. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR et al., MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006;47:98-107.
9. Hohnloser SH, Klingenheben T, Zabel M, Shopperl M, Mauss O. Prevalence, characteristics and prognostic value during long term follow up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;33:1895-902.
10. Senges JC, Becker R, Schreiner KD, Bauer A, Weretka S, Siegler K et al. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial. Pacing Clin Electrophysiol 2002;25:183-90.
11. Wichterle D, Simek J, Camm J, Malik M. Predictive characteristics of holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. Pacing Clin Electrophysiol 2005;28:S182-6.
12. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993;87:312-22.
13. Pacemakers and implantable defibrillators: a two year national survey for 2003 and 2004. Network Devices Survey Group. http://www.devicesurvey.com.
14. TA95 arrhythmia-implantable cardioverter defibrillators (ICDs): analysis of cost impact. http://guidance.nice.org.uk/TA95/costtemplate/xls/English.
15. Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005;26:762-9.
16. Morgan JM, Cowan JC, Camm AJ, McComb JM. Sudden cardiac death: opportunities for prevention. Heart 2006;92:721-3.
17. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
18. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2006;27:2099-140.